Molecular Dominoes
Chemické listy · 15.11.2026 · 120 (11) · 664-669
DOI: 10.54779/chl20260664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemické listy, online erschienen am 15.11.2026. Verfasst von Tereza Gistrová und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Self-immolative (SI) linkers are covalently bound constructs designed to decouple the initial activation of a precursor from the final release of the active compound. A typical system comprises a trigger, a central spacer and a cargo. Removal of the protecting group by an external chemical, enzymatic or photochemical stimulus initiates spontaneous cascading fragmentation and liberates the payload. This allows the biological activity of a drug to be temporarily masked, overcoming limitations such as suboptimal pharmacokinetics, insufficient selectivity or poor aqueous solubility. This review summarises the two principal fragmentation mechanisms – electronic cascades of electron-rich aromatics and cyclisation into thermodynamically favoured five- and six-membered rings, together with the factors governing release kinetics. Particular attention is paid to phosphorus-based linkers which, unlike carbamate systems, accommodate a third substituent and thus enable dual cargo delivery, bioconjugation or attachment of a fluorescent label. Applications in medicinal chemistry, antibody–drug conjugates and degradable materials are also discussed. Full text English translation is available in the on-line version.
Zitieren
APA
Gistrová, T., & Baszczyňski, O. (2026). Molecular Dominoes. Chemické listy, 120(11), 664-669. https://doi.org/10.54779/chl20260664
Vancouver
Gistrová T, Baszczyňski O. Molecular Dominoes. Chemické listy. 2026;120(11):664-669. doi:10.54779/chl20260664
BibTeX
@article{Gistrov2026,
author = {Gistrová, Tereza and Baszczyňski, Ondřej},
title = {Molecular Dominoes},
journal = {Chemické listy},
year = {2026},
volume = {120},
number = {11},
pages = {664--669},
doi = {10.54779/chl20260664}
}
EUVIMED